Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yellow fever vaccine human infection model study
NL-OMON54831Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2023
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of 17D yellow fever vaccine in yellow fever, sponsored by Leiden University Medical Center. Primary endpoints: Percentage of participants with measurable viruria after yellow fever vaccination and Peak of viruria after yellow fever vaccination. Started Feb 2023; status: recruiting.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NL-OMON54831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54831.